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suffruticosum for hypolipidemic activity in rats fed
with high Fat diet
Satheesh Kumar Dharmarajan and Kottai Muthu Arumugam*Abstract
The objective of the study is a comparative evaluation of flavone isolated from Mucuna pruriens and coumarin
isolated from Ionidium suffruticosum was assessed for the hypolipidemic activity in rats fed with high fat diet. The
acute toxicity study was found that flavone (M.pruriens) and coumarin (I.suffruticosum) are safe up to 100mg/kg, so
one tenth of this dose (10mg/kg) was consider as a evaluation dose. High fat diet group of rats showed significant
(p<0.001) elevation in plasma total and LDL-cholesterol, triglycerides and phospholipids. Administration of flavone
(M. pruriens) and coumarin isolated from (I.suffruticosum) at the dose of 10mg/kg b.wt/day along with high fat diet
significantly (p<0.001) prevented the rise in the plasma total and LDL-cholesterol, triglycerides and phospholipids
than that of other extracts. However, treatment of coumarin isolated from (I.suffruticosum) had showed more cardio
protective effect against hyperlipidemia than that of flavone (M.pruriens).
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Cardiovascular disease is a major problem worldwide.
The World Health Organization estimates that this dis-
ease is responsible for the deaths of approximately
30,000 people each day [1]. Hyperlipidaemia is charac-
terized by elevated serum total cholesterol, low-density
lipoprotein cholesterol, very low density lipoprotein
cholesterol and decreased high-density lipoprotein chol-
esterol levels [2]. As reported in literature synthetic
drugs may be having serious side effects [3]. Statins may
also be associated with some other rarely occurring side
effects like nausea, abdominal pain, dyspepsia, diarrhoea
or constipation and flatulence [4]. Medicinal plants, on
the other hand, have been reported safer as compared
topharmaceutically derived remedies [2].
Mucuna pruriens Linn belongs to the family fabaceae,
traditionally in India the seeds of Mucuna pruriens are
used as a tonic and aphrodisiac for male virility. It has
been reported to be antidiabetic [5], analgesic and anti-* Correspondence: arthik03@yahoo.com
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distribution, and reproduction in any mediuminflammatory [6]. Its different preparations (from seeds)
are used for the management of several free radical-
mediated diseases such as ageing, rheumatoid arthritis,
diabetes, atherosclerosis, male infertility and nervous
disorders. Ionidium suffruticosum (Ging.) it belongs to
the family Violaceae, it is widely used as traditional hea-
lers for the treatment of diseases like diabetes [7], male
sterility [8], urinary tract infections and water retention
[9]. Hence, the attempt is made for the comparative
evaluation of flavone from Mucuna pruriens and Cou-
marin isolated from Ionidium suffruticosum for hypolipi-
demic activity in rats fed with high fat diet.Materials and methods
Collection and identification of plant materials
The whole plant of Mucuna pruriens (Linn), were col-
lected from Neiyur dam, Kanyakumari District of Tamil
Nadu, India and the whole plant of Ionidium suffrutico-
sum (Ging) were collected from Kilikulam, Tirunelveli
District of Tamil Nadu, India. The taxonomic identifica-
tion was made from Botanical Survey of Medicinal
Plants Unit Siddha, Government of India, Palayamkottai.entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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dium suffruticosum (Ging) were dried under shade, seg-
regated, pulverized by a mechanical grinder and passed
through a 40 mesh sieve. The powdered plant materials
were stored in an airtight container.
Chemicals
All the chemicals used in the study were of analytical
grade, procured from the credible concerns e.g.: Sigma,
Merck and Qualigens. Atorvastatin was provided as a
generous gift sample by Ranbaxy Pharmaceuticals, India.
Preparation of various extracts from Mucuna pruriens and
ionidium suffruticosum
The whole plant of Mucuna pruriens (Linn) and Ioni-
dium suffruticosum (Ging) were dried in shade and pow-
dered. The powdered plant materials were successively
extracted with petroleum ether (40-60°C) by hot con-
tinuous percolation method in Soxhlet apparatus [10]
for 24 hrs. Then the marc was dried and then subjected
to ethyl acetate (76-78°C) for 24 hrs, then marc was
dried and then it was subjected to methanol (80°C) for
24 hrs. The solvent from the extracts was recovered
under reduced pressure using rotary evaporator and sub-
jected to freeze drying in a lyophilizer till dry powder
was obtained.
Isolation of flavone from methanol extract of Mucuna
pruriens
The methanol extract of Mucuna pruriens was subjected
to column chromatographic separation using normal
phase silica gel column. The dark brown solid (20 g
methanol extract of Mucuna pruriens) was adsorbed on
silica gel (20 g) and transferred to a column of silica gel
(200g equilibrated with benzene). Flavone (265mg) was
eluted with ethyl acetate: methanol, 80:20 v/v from
methanol extract of Mucuna pruriens.
Isolation of coumarin from methanolic extract of ionidium
suffruticosum
The methanolic extract of Ionidium suffruticosum was
subjected to column chromatographic separation using
normal phase silica gel column. The dark brown solid
(20 g methanolic extract of Ionidium suffruticosum) was
adsorbed on silica gel (20 g) and transferred to a column
of silica gel (200g equilibrated with benzene). The Cou-
marin derivative (245 mg) was eluted with benzene:
Chloroform 70:30, v/v from methanolic extract of Ioni-
dium suffruticosum.
Experimental animals
Healthy male Wistar rats (weighing 120-150g) were pro-
cured from Central Animal House, Rajah Muthiah Med-
ical College, Annamalai University. The animals werekept in cages, 2 per cage, with relative humidity (55%) in
a 12 hour light/dark cycle at 25±2°C. They were given
access to water and a commercial diet ad libitum. The
experiment were carried out as per the guidelines of
Committee for the Purpose of Control and Supervision
of Experiments on Animals (CPCSEA), New Delhi,
India, and approved by the Institutional Animal Ethics
Committee (IAEC), Annamalai University (Approved
number: 160/1999/CPCSEA/745).Acute toxicity studies
Acute oral toxicity study was performed as per
Organization and Economic Cooperation and Develop-
ment (OECD) guidelines 423 adopted on 17th December
2001 received from Committee for the purpose of Control
and Supervision of Experimental Animals (CPCSEA). The
rats were fed with flavone from Mucuna pruriens and
Coumarin derivatives from Ionidium suffruticosum sus-
pended in 1% gum acacia at the dose of 100mg/kg body
weight. The animals were observed individually every 30
minutes after dosing the first 24hrs and thereafter daily
for a total of 14 days. The time at which signs of toxicity
appear and disappear was observed systematically and
recorded for each animal.Experimental induction of hyperlipidemia
High fat diet was prepared by mixing Wheat flour
20.5%, roasted bengal gram 52.6%, skimmed milk pow-
der 5%, casein 4%, refined oil 4%, coconut oil 9%, salt
mixture with starch 4% and vitamin & choline mixture
0.5%, cholesterol 0.4% [11]. The diet was placed in the
cage carefully and was administered for 14 days [12].Protocol for antihyperlipidemic activity
In the experiment a total number of 36 rats were used.
The rats were divided into five groups of six each. Group
I: control, Group II: High Fat Diet (HFD), Group III:
HFD plus Flavone (M. pruriens) at the dose of 10mg/kg
b.wt, Group IV: HFD plus Coumarin (I. suffruticosum) at
the dose of 10mg/kg b.wt, Group V: HFD + standard
drug atorvastatin (1.2 mg/kg b.wt). The drugs were sus-
pended in 2% tween 80 [13] separately and fed to the re-
spective rats by oral intubation. At the end of the study
all the rats were sacrificed by cervical dislocation after
overnight fasting. Just before sacrifice, blood was col-
lected from the retro-orbital sinus plexus under mild
ether anaesthesia and blood sample collected in hepari-
nised tubes and plasma was separated. Liver, heart and
aorta were cleared of adhering fat, weighed accurately
and used for the preparation of homogenate. Animals
were given enough care as per the Animal Ethical Com-
mittee’s recommendations.
Table 1 Average Body weight changes in control and experimental rats
Groups Initial Weight (g) Final Weight (g) Average Body weight gain (g)
Group I 137.34±0.47bNS 156.66±2.47b* 19.32±2.39b*
Group II 136.33±0.42aNS 198.64±2.58a* 62.31±1.90a*
Group III 136.71±0.41aNS,bNS 162.33±2.16aNS,b** 25.62±2.54aNS, b*
Group IV 136.57±0.53aNS,bNS 161.26±1.38aNS,b* 24.69±3.28aNS,b*
Group V 137.55±0.74aNS,bNS 161.51±1.74aNS,b* 23.96±3.39 aNS,b*
Values are expressed as mean ± SE (n=6 rats); P values: *<0.001, **<0.05; NS: Non significant; a! group I compared with groups II, III, IV& V; b ! group II
compared with groups III, IV& V; Group I : Standard chow diet (Control); Group II : High Fat Diet (Negative Control); Group III : HFD + Flavone (M.pruriens) (10mg/kg
b.wt); Group IV : HFD+Coumarin (I. suffruticosum) (10mg/kg b.wt); Group V : HFD + Atorvastatin (1.2 mg/kg b.wt) (Positive Control).
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Plasma samples were analyzed for total cholesterol,
HDL-cholesterol and triglycerides using Boehringer
Mannheim kits by Erba Smart Lab analyzer USA. LDL-
cholesterol and VLDL-cholesterol were calculated by
using Friedwald method [14]. Ester cholesterol [15] and
free cholesterol [15] were analyzed by using digitonin.
Portions of liver, heart and aorta tissues were blotted,
weighed and homogenized with methanol (3 volumes)
and the lipid extracts were obtained by the method of
Folch et al. (1957) [16]. Extracts were used for the esti-
mation of ester cholesterol and free cholesterol, trigly-
cerides [17], and phospholipids [18]. The atherogenic
Index was calculated by using the following formula.
Athorogenic Index ¼ Total cholesterol
HDL
Statistical analysis
Results were expressed as mean ± SE of 6 rats in each
group. The data were also analysed by one way analysis
of variance (ANOVA) followed by Dunnet’s t-test. ‘P,
value less than 0.05 is considered significant.
Results and discussion
Balance between synthesis and degradation of biological
tissues is maintained by Lipid metabolism. Development
of hyperlipidemia disease is a complicated process in-
volving accumulation of lipid containing particles in the
walls of coronary arteries & other major arteries withinTable 2 Effect of flavone from Mucuna pruriens and coumarin







Group I 69.81±0.51b* 23.67±0.43b* 46.14±0.61b
Group II 167.17±0.26a* 49.41±0.12a* 117.76±0.57a
Group III 77.43 ±0.29a*,b* 24.36±0.74a*,b* 53.07±0.82a
Group IV 72.74±0.47a*,b* 23.05±0.40a*,b* 49.69±0.22a
Group V 72.92 ±0.22a*,b* 23.44±0.55a*,b* 49.48±0.56
Values are expressed as mean ± SE (n=6 rats); P values: * < 0.001, ** < 0.05; NS: Non
compared with groups III, IV, V; Details of group I-V are same as in Table 1.the body. A high-fat diet causes cholesterol levels to in-
crease in susceptible people, which leads to obesity.
The flavone isolated from Mucuna pruriens and cou-
marin derivatives isolated from Ionidium suffruticosum
were found to be non-toxic upto the dose of 100mg/kg
and did not cause any death of the tested animals.
Therefore, one tenth of this dose (10mg/kg) was consid-
ered as the evaluation dose. As shown in Table 1, the
weight gain in HFD group of rats significantly (p<0.001)
higher than control rats reflecting the influence of high
fat diet. The increment in the weight reduced signifi-
cantly (p<0.001) by the administration of flavone from
(M.pruriens) (Group III) and Coumarin (I. suffruticosum)
(Group IV) at the dose of 10mg/kg as well as atorvasta-
tin 1.2mg/kg in comparison with the HFD fed rats
(Group II). Administration of Coumarin (I. suffrutico-
sum) at the dose of 10mg/kg exhibited the significant re-
duction in bodyweight in comparison with the group
received flavone (M. pruriens) (Group III). The weight
reducing effect may be attributed to its potential to in-
hibit lipogenesis and enhanced thermogenesis, since
obesity is associated with defective thermogenesis [19].
As shown in Table 2, HFD rats are showed significant
increase (p<0.001) in plasma total cholesterol level as
compared to control rats (group I). Earlier studies reveal
significant elevation of lipid parameters in plasma and
tissue response to atherogenic diet or high fat diet
[20,21]. Treatment with flavone isolated from Mucuna
pruriens and coumarin derivatives isolated from Ioni-






* 155.87±0.24b* 78.57 ±0.20b* 2.90±0.08b*
* 208.33±0.33a* 121.83±0.33a* 9.73±0.21a*
*,b* 160.71±0.34a*,b* 84.03±0.40a*,b* 3.35±0.18a*,b*
*,b* 156.47±0.12a*,b* 79.47±0.37a*,b* 2.88±0.84a*,b*
a*,b* 156.29±0.28a*,b* 80.19 ±0.07a*,b* 2.97±0.53a*,b*
Significant; a !group I compared with groups II, III, IV, V; b!group II
Table 3 Effect of flavone from Mucuna pruriens and
coumarin from Ionidium suffruticosum on tissues ester
cholesterol profile in control and experimental rats
Groups Ester cholesterol (mg/g tissue)
Liver Heart Aorta
Group I 0.67 ± 0.02b* 2.86± 0.01b* 2.02±0.42b*
Group II 2.55±0.04a* 6.96±0.02a* 6.81±0.23a*
Group III 2.02±0.01a*,b** 3.78±0.03a*,b* 4.98±0.24a*,b*
Group IV 2.59±0.03 a*,b* 3.10±0.01a*,b* 2.69±0.09a*,b*
Group V 1.84±0.01a*,b* 2.98±0.01a*,b* 2.83±0.11a*,b*
Values are expressed as mean ± SE (n=6 rats); P values: * < 0.001, ** < 0.05; NS:
Non Significant; a!group I compared with groups II, III, IV, V; b !group II
compared with groups III, IV, V; Details of group I-V are same as in Table 1.
Table 5 Effect of flavone from Mucuna pruriens and
coumarin from Ionidium suffruticosum on tissues
Triglyceride level in control and experimental rats
Groups Triglyceride (mg/g tissue)
Liver Heart Aorta
Group I 7.95±0.01b* 9.17±0.01b* 9.48±0.33b*
Group II 18.11±0.19a* 28.79±0.16a* 19.37±0.78a*
Group III 9.57±0.15a*, b* 16.78± 0.21a**,b* 12.67±0.11a*,b*
Group IV 8.24±0.10a*,b* 15.47 ± 0.12a*,b* 12.08 ± 0.12a*,b*
Group V 8.31±0.69a*,b* 15.21±0.36a*,b* 12.15 ± 0.01a*,b*
Values are expressed as mean ± SE (n=6 rats); P values: * < 0.001, ** < 0.05; NS:
Non Significant; a!group I compared with groups II, III, IV, V; b !group II
compared with groups III, IV, V; Details of group I-V are same as in Table 1.
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cholesterol level compared to HFD rats (group II). Low-
ering high cholesterol levels significantly reduced the
risk of heart attacks, strokes, and death. However, the
rats received coumarin (I. suffruticosum) at the dose of
10mg/kg b.wt (Group IV) with HFD had showed
restored the plasma cholesterol level near to normal as
that of standard (Group V).
As shown in Tables 2, 3 and 4, the significant
(P<0.001) increase in levels of both free and ester chol-
esterol were also observed in plasma and tissue of rats
fed with high fat diet (group II) when compared to con-
trol rats (group I). This high cholesterol concentration
in circulation may damage the endothelial cells lining
the large arteries and aorta and this may be an initial
event in the etiology of atherosclerosis [22]. Both plasma
free and ester cholesterol reduced remarkably on treat-
ing the HFD rats with flavone (M. pruriens) and couma-
rin (I. suffruticosum) at the dose of 10mg/kg body
weight. This lipid lowering effect may be due to the in-
hibition of hepatic cholesterogenesis or due to the in-
crease in excretion of fecal sterol [23].
As shown in Tables 2 and 5. The concentration of
plasma and tissue triglyceride elevated in rats fed with
high fat diet (group II) as compared to control ratsTable 4 Effect of flavone from Mucuna pruriens and
coumarin from Ionidium suffruticosum on tissues free
cholesterol profile in control and experimental rats
Groups Free cholesterol (mg/g tissue)
Liver Heart Aorta
Group I 0.65±0.01b* 0.69± 0.01b* 0.40±0.01b*
Group II 1.24±0.01a** 1.17±0.03 a* 1.86±0.02a*
Group III 0.89 ±0.01a*,b** 0.12±0.01a**,b* 0.73±0.01a*,b*
Group IV 0.73±0.01a*,b* 0.66±0.01a*,b* 0.62±0.01a*,b*
Group V 0.81±0.04a*,b* 0.64±0.04a*,b* 0.63±0.04a*,b*
Values are expressed as mean ± SE (n=6 rats); P values: * < 0.001, ** < 0.05; NS:
Non Significant; a!group I compared with groups II, III, IV, V; b !group II
compared with groups III, IV, V; Details of group I-V are same as in Table 1.(group I). HFD rats had significant increase in the level
of plasma triglyceride due to decrease in the activity of
lipoprotein lipase [24,25]. Both plasma and tissue trigly-
ceride levels were significantly reduced in rats treated
with flavone (M. pruriens) at the dose of 10mg/kg body
weight, coumarin (I. suffruticosum) at the dose of 10mg/kg
body weight and as well as standard drug atorvastatin along
with HFD when compared with rats fed with high fat
diet (group II). Administration of coumarin (I. suffru-
ticosum) at the dose of 10mg/kg body weight reduced
the triglyceride level significantly (p<0.001) in com-
parison with flavone (M. pruriens). The flavone (M.
pruriens) and coumarin (I. suffruticosum) may have
stimulation of lipoprotein lipase activities resulting in
decrease of plasma triglyceride and might increase the
uptake of triglyceride from plasma by skeletal muscle
and adipose tissues [26].
As shown in Tables 2 and 6, the concentration of
plasma and tissue phospholipids significantly increased
in rats fed HFD (group II) as compared to control ani-
mals (group I). This may be due to decreased phospoli-
pase activity [27]. (Group II). Both plasma and tissue
phospholipids levels significantly decreased in rats trea-
ted with flavone (M. pruriens) 10mg/kg body weight and
coumarin (I. suffruticosum) 10mg/kg body weight and asTable 6 Effect of flavone from Mucuna pruriens and
coumarin from Ionidium suffruticosum on tissues
Phospholipids level in control and experimental rats
Groups Phospholipids (mg/g tissue)
Liver Heart Aorta
Group I 12.37±0.45b* 18.04 ±0.67b* 10.32±0.05b*
Group II 25.14±0.69a* 26.47±0.10a* 17.45± 0.29a*
Group III 17.81 ± 0.01a*,b* 20.14±0.65a*,b* 13.06± 0.13a*,b**
Group IV 16.45±0.06a*,b* 19.45±0.73a*,b* 12.47±0.12a*,b*
Group V 17.45±0.77a*,b* 19.08±0.18a*,b** 12.02± 0.10a*,b*
Values are expressed as mean ± SE (n=6 rats); P values: * < 0.001, ** < 0.05; NS:
Non Significant; a!group I compared with groups II, III, IV, V; b !group II
compared with groups III, IV, V; Details of group I-V are same as in Table 1.
Table 7 Effect of flavone from Mucuna pruriens and coumarin from Ionidium suffruticosum on plasma lipoprotein in
control and experimental rats
Groups HDL cholesterol (mg/dl) LDL cholesterol (mg/dl) VLDL cholesterol (mg/dl)
Group I 24.04±0.16b* 30.06±0.41b* 15.71±0.10b*
Group II 17.17±0.22a* 125.64±0.55a* 24.36±0.17a*
Group III 23.11±0.12a*,b* 37.52± 0.37a*,b* 16.80±0.20a*,b **
Group IV 25.27±0.19a*,b* 31.58± 0.08a*,b* 15.89±0.18 a**,b*
Group V 24.51±0.26a*, b* 32.37± 0.19a*,b* 16.04±0.03a*,b*
Values are expressed as mean ± SE (n=6 rats); P values: * < 0.001, ** < 0.05; NS: Non Significant; a !group I compared with groups II, III, IV, V; b!group II
compared with groups III, IV, V; Details of group I-V are same as in Table 1.
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compared with rats fed with high fat diet (group II).
Whereas, the rats received coumarin (I. suffruticosum) at
the dose of 10mg/kg body weight (Group IV) exhibited
significant reduction in triglyceride level in comparison
with flavone (M. pruriens) (Group III). The reduced con-
centration of phospholipids may also be due to the
enhanced activity of phospholipases [11].
Atherogenic Index (AI) indicates the deposition of
foam cells or plaque or fatty infiltration or lipids in
heart, coronaries, aorta, liver and kidney. The higher the
AI, higher is the risk of above organs for oxidative dam-
age. As shown in Table 2, the atherogenic index (TG/
HDL-C ratio) used to predict risk of CHD and marker
of small, dense LDL-C (an atherogenic lipoprotein)
[28,29] were significantly reduced by the flavone from
M.pruriens and coumarin from I.suffruticosum, indicat-
ing the beneficial effect of flavone and coumarin in car-
diovascular diseases.
As shown in Table 7, the reduction in the HDL pro-
duced by the group of animals fed with HFD was signifi-
cant (P<0.001) in comparison with group I animals. This
result is highly significant in that low HDL-cholesterol is
now considered as the most significant risk factor for
atherosclerosis [30] (Brewer, 2004). However, the treat-
ment with flavone isolated from Mucuna pruriens
(Group III) and coumarin derivatives isolated from Ioni-
dium suffruticosum (Group IV) had significantly
increased the HDL-cholesterol level when compared to
HFD rats (Group II). It has clearly been demonstrated
that a relationship exists between increased concentra-
tion of HDL-C and decreased morbidity-and mortality-
rate in cardiovascular patients [31].
As shown in Table 7, the elevated levels of LDL and
VLDL-cholesterol in rats fed with HFD (group II) was
significant (P<0.001) in comparison with control rats
(group I). High cholesterol diet increased serum choles-
terol and LDL-C level significantly. Clinical and epi-
demiological studies have proved that individuals with
elevated LDL show an increased risk for cardiovascular
diseases [32]. Treatment of flavone from M.pruriens
(Group III) and coumarin from I.suffruticosum (Group
IV) markedly reduced the level of plasma LDL-cholesterol and VLDL-cholesterol when compared to
HFD rats (group II). In comparison of flavone from Mu-
cuna pruriens (Group III) and coumarin from Ionidium
suffruticosum (Group IV) with HFD (Group II) rats, the
coumarin from Ionidium suffruticosum (Group IV) was
showed significant reduction on both LDL-cholesterol
and VLDL-cholesterol than that of group III rats. Recent
research has revealed that a 4-5% decrease in LDL-
cholesterol results in a 5-10% decrease in the occurrence
of coronary heart disease (CHD) [33].
Conclusion
On the basis of the present investigation was observed
as the Coumarin derivatives isolated from Ionidium suf-
fruticosum had showed a better antihyperlipidemic activ-
ity in comparison with flavone isolated from Mucuna
pruriens. The Coumarin derivatives isolated from Ioni-
dium suffruticosum is beneficial in preventing hypercho-
lesterolemic atherosclerosis and reducing risk factors for
coronary artery disease.
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